IL1B and cardiovascular disorder: A resent study demonstrated that an antibody targeting IL-1β can inhibit the progression of atherosclerosis in vivo, highlighting the importance of this key cytokine in cardiovascular disease [41].Therefore, IL-1β and TNF-α are two important pro-inflammatory cytokines in the initiation and development of atherosclerosis.